vs
EVI INDUSTRIES, INC.（EVI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是EVI INDUSTRIES, INC.的1.7倍（$197.9M vs $115.3M），REPLIGEN CORP净利率更高（6.7% vs 2.1%，领先4.7%），EVI INDUSTRIES, INC.同比增速更快（24.4% vs 13.6%），过去两年EVI INDUSTRIES, INC.的营收复合增速更高（17.2% vs 14.4%）
EVI Industries是一家商用洗衣、干洗及衣物护理设备的领先分销商，主要服务北美市场，客户涵盖自助洗衣店、酒店、医疗机构及多户住宅物业，同时提供设备安装、维护及售后支持服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EVI vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$115.3M
营收增速更快
EVI
高出10.7%
13.6%
净利率更高
RGEN
高出4.7%
2.1%
两年增速更快
EVI
近两年复合增速
14.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.3M | $197.9M |
| 净利润 | $2.4M | $13.3M |
| 毛利率 | 30.8% | 52.5% |
| 营业利润率 | 3.7% | 9.0% |
| 净利率 | 2.1% | 6.7% |
| 营收同比 | 24.4% | 13.6% |
| 净利润同比 | 109.9% | 143.9% |
| 每股收益（稀释后） | $0.15 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVIRGEN
| Q4 25 | $115.3M | $197.9M | ||
| Q3 25 | $108.3M | $188.8M | ||
| Q2 25 | $110.0M | $182.4M | ||
| Q1 25 | $93.5M | $169.2M | ||
| Q4 24 | $92.7M | $174.1M | ||
| Q3 24 | $93.6M | $154.9M | ||
| Q2 24 | $90.1M | $154.1M | ||
| Q1 24 | $84.0M | $151.3M |
净利润EVIRGEN
| Q4 25 | $2.4M | $13.3M | ||
| Q3 25 | $1.8M | $14.9M | ||
| Q2 25 | $2.1M | $14.9M | ||
| Q1 25 | $1.0M | $5.8M | ||
| Q4 24 | $1.1M | $-30.3M | ||
| Q3 24 | $3.2M | $-654.0K | ||
| Q2 24 | $2.1M | $3.3M | ||
| Q1 24 | $956.0K | $2.1M |
毛利率EVIRGEN
| Q4 25 | 30.8% | 52.5% | ||
| Q3 25 | 31.3% | 53.2% | ||
| Q2 25 | 30.8% | 50.0% | ||
| Q1 25 | 30.0% | 53.6% | ||
| Q4 24 | 29.7% | 26.1% | ||
| Q3 24 | 30.8% | 50.0% | ||
| Q2 24 | 30.4% | 49.8% | ||
| Q1 24 | 30.7% | 49.5% |
营业利润率EVIRGEN
| Q4 25 | 3.7% | 9.0% | ||
| Q3 25 | 3.3% | 8.9% | ||
| Q2 25 | 3.7% | 7.6% | ||
| Q1 25 | 2.4% | 3.9% | ||
| Q4 24 | 2.6% | -17.7% | ||
| Q3 24 | 5.3% | -5.1% | ||
| Q2 24 | 4.1% | 1.0% | ||
| Q1 24 | 2.9% | 1.3% |
净利率EVIRGEN
| Q4 25 | 2.1% | 6.7% | ||
| Q3 25 | 1.7% | 7.9% | ||
| Q2 25 | 1.9% | 8.2% | ||
| Q1 25 | 1.1% | 3.4% | ||
| Q4 24 | 1.2% | -17.4% | ||
| Q3 24 | 3.5% | -0.4% | ||
| Q2 24 | 2.3% | 2.2% | ||
| Q1 24 | 1.1% | 1.4% |
每股收益（稀释后）EVIRGEN
| Q4 25 | $0.15 | $0.24 | ||
| Q3 25 | $0.11 | $0.26 | ||
| Q2 25 | $0.14 | $0.26 | ||
| Q1 25 | $0.07 | $0.10 | ||
| Q4 24 | $0.07 | $-0.55 | ||
| Q3 24 | $0.21 | $-0.01 | ||
| Q2 24 | $0.13 | $0.06 | ||
| Q1 24 | $0.06 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $144.0M | $2.1B |
| 总资产 | $315.6M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EVIRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $4.7M | $748.7M | ||
| Q2 25 | $8.9M | $708.9M | ||
| Q1 25 | $5.9M | $697.2M | ||
| Q4 24 | $3.9M | $757.4M | ||
| Q3 24 | $4.4M | $784.0M | ||
| Q2 24 | $4.6M | $809.1M | ||
| Q1 24 | $3.3M | $780.6M |
总债务EVIRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $24.0M | — | ||
| Q4 24 | $27.9M | $525.6M | ||
| Q3 24 | $19.9M | — | ||
| Q2 24 | $12.9M | — | ||
| Q1 24 | $21.9M | — |
股东权益EVIRGEN
| Q4 25 | $144.0M | $2.1B | ||
| Q3 25 | $140.8M | $2.1B | ||
| Q2 25 | $143.5M | $2.1B | ||
| Q1 25 | $140.2M | $2.0B | ||
| Q4 24 | $138.0M | $2.0B | ||
| Q3 24 | $136.1M | $2.0B | ||
| Q2 24 | $136.6M | $2.0B | ||
| Q1 24 | $133.5M | $2.0B |
总资产EVIRGEN
| Q4 25 | $315.6M | $2.9B | ||
| Q3 25 | $321.8M | $2.9B | ||
| Q2 25 | $307.0M | $2.9B | ||
| Q1 25 | $251.8M | $2.9B | ||
| Q4 24 | $248.8M | $2.8B | ||
| Q3 24 | $245.5M | $2.8B | ||
| Q2 24 | $230.7M | $2.9B | ||
| Q1 24 | $239.3M | $2.8B |
负债/权益比EVIRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.20× | 0.27× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 1.70× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流EVIRGEN
| Q4 25 | $4.0M | $25.7M | ||
| Q3 25 | $1.0M | $48.1M | ||
| Q2 25 | $9.9M | $28.6M | ||
| Q1 25 | $9.1M | $15.0M | ||
| Q4 24 | $2.0M | $39.2M | ||
| Q3 24 | $207.0K | $49.3M | ||
| Q2 24 | $12.4M | $42.2M | ||
| Q1 24 | $9.4M | $44.7M |
自由现金流EVIRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $-890.0K | $43.4M | ||
| Q2 25 | $8.2M | $21.5M | ||
| Q1 25 | $8.1M | $11.4M | ||
| Q4 24 | $1.1M | $33.6M | ||
| Q3 24 | $-1.0M | $42.3M | ||
| Q2 24 | $11.2M | $37.4M | ||
| Q1 24 | $8.1M | $36.4M |
自由现金流率EVIRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | -0.8% | 23.0% | ||
| Q2 25 | 7.5% | 11.8% | ||
| Q1 25 | 8.7% | 6.8% | ||
| Q4 24 | 1.2% | 19.3% | ||
| Q3 24 | -1.1% | 27.3% | ||
| Q2 24 | 12.4% | 24.3% | ||
| Q1 24 | 9.7% | 24.0% |
资本支出强度EVIRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 1.8% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 1.1% | 2.1% | ||
| Q4 24 | 0.9% | 3.2% | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 1.3% | 3.1% | ||
| Q1 24 | 1.5% | 5.5% |
现金转化率EVIRGEN
| Q4 25 | 1.70× | 1.93× | ||
| Q3 25 | 0.55× | 3.23× | ||
| Q2 25 | 4.74× | 1.92× | ||
| Q1 25 | 8.79× | 2.57× | ||
| Q4 24 | 1.74× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 5.99× | 12.70× | ||
| Q1 24 | 9.85× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
